speb/financial-data huggingface dataset:
RXST cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -581000.00
RXST balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 275970000.00
RXST income_statement (quarterly, 2025-09-30) — Normalized EBITDA: -8948000.00
RXST income_statement (quarterly, 2025-09-30) — Normalized Income: -9816000.00
RXST cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: -1187000.00
RXST income_statement (quarterly, 2025-09-30) — Operating Income: -12178000.00
RXST income_statement (quarterly, 2025-09-30) — Operating Revenue: 30340000.00
RXST balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 41081550.00
RXST balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 3260000.00
RXST balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: 60000.00
RXST balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 1284000.00
RXST balance_sheet (quarterly, 2025-09-30) — Other Properties: 10276000.00
RXST balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 197883000.00
RXST balance_sheet (quarterly, 2025-09-30) — Payables: 3377000.00
RXST balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 20998000.00
RXST balance_sheet (quarterly, 2025-09-30) — Preferred Stock: 0.00
RXST income_statement (quarterly, 2025-09-30) — Pretax Income: -9806000.00
RXST balance_sheet (quarterly, 2025-09-30) — Properties: 13096000.00
RXST cash_flow (quarterly, 2025-09-30) — Provisionand Write Offof Assets: 66000.00
RXST cash_flow (quarterly, 2025-09-30) — Purchase Of Investment: -68423000.00
RXST cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -581000.00
RXST balance_sheet (quarterly, 2025-09-30) — Raw Materials: 7360000.00
RXST balance_sheet (quarterly, 2025-09-30) — Receivables: 24151000.00
RXST income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 6113000.00
RXST income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 854000.00
RXST cash_flow (quarterly, 2025-09-30) — Repayment Of Debt: -19000.00
RXST income_statement (quarterly, 2025-09-30) — Research And Development: 9060000.00
RXST balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -651887000.00
RXST cash_flow (quarterly, 2025-09-30) — Sale Of Investment: 60000000.00
RXST income_statement (quarterly, 2025-09-30) — Selling General And Administration: 27345000.00
RXST balance_sheet (quarterly, 2025-09-30) — Share Issued: 41081550.00
RXST cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 8108000.00
RXST balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 275970000.00
RXST balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 275970000.00
RXST income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
RXST income_statement (quarterly, 2025-09-30) — Tax Provision: 10000.00
RXST income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.21
RXST balance_sheet (quarterly, 2025-09-30) — Total Assets: 308533000.00
RXST balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 275970000.00
RXST balance_sheet (quarterly, 2025-09-30) — Total Debt: 11565000.00
RXST balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 275970000.00
RXST income_statement (quarterly, 2025-09-30) — Total Expenses: 42518000.00
RXST balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 32563000.00
RXST balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 24656000.00
RXST balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 10272000.00
RXST income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: -12178000.00
RXST balance_sheet (quarterly, 2025-09-30) — Work In Process: 4407000.00
RXST balance_sheet (quarterly, 2025-09-30) — Working Capital: 261586000.00
RXST income_statement (annual, 2025-12-31) — +Operating Expense: 151200000.00
RXST income_statement (quarterly, 2025-12-31) — +Operating Expense: 36600000.00
RXST income_statement (annual, 2025-12-31) — +Total Revenue: 134479000.00
RXST income_statement (quarterly, 2025-12-31) — +Total Revenue: 32608000.00
RXST balance_sheet (annual, 2025-12-31) — Accounts Payable: 5296000.00
RXST balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 5296000.00
RXST balance_sheet (annual, 2025-12-31) — Accounts Receivable: 23383000.00
RXST balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 23383000.00
RXST balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -26568000.00
RXST balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -26568000.00
RXST balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 936628000.00
RXST balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 936628000.00
RXST cash_flow (annual, 2025-12-31) — Amortization Of Securities: -8517000.00
RXST cash_flow (quarterly, 2025-12-31) — Amortization Of Securities: -1832000.00
RXST income_statement (annual, 2025-12-31) — Basic Average Shares: 40850739.00
RXST income_statement (quarterly, 2025-12-31) — Basic Average Shares: 41175725.00
RXST income_statement (annual, 2025-12-31) — Basic EPS: -0.95
RXST income_statement (quarterly, 2025-12-31) — Basic EPS: -0.22
RXST cash_flow (annual, 2025-12-31) — Beginning Cash Position: 17456000.00
RXST cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 30382000.00
RXST cash_flow (annual, 2025-12-31) — Capital Expenditure: -3830000.00
RXST cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -1137000.00
RXST balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 11040000.00
RXST balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 11040000.00
RXST balance_sheet (annual, 2025-12-31) — Capital Stock: 41000.00
RXST balance_sheet (quarterly, 2025-12-31) — Capital Stock: 41000.00
RXST balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 19949000.00
RXST balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 19949000.00
RXST balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 228128000.00
RXST balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 228128000.00
RXST cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: 1863000.00
RXST cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: 1063000.00
RXST cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: 16889000.00
RXST cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -9614000.00
RXST cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: -15511000.00
RXST cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: -1116000.00
RXST cash_flow (annual, 2025-12-31) — Change In Account Payable: 627000.00
RXST cash_flow (quarterly, 2025-12-31) — Change In Account Payable: 2204000.00
RXST cash_flow (annual, 2025-12-31) — Change In Accrued Expense: -1875000.00
RXST cash_flow (quarterly, 2025-12-31) — Change In Accrued Expense: 1698000.00
RXST cash_flow (annual, 2025-12-31) — Change In Inventory: -11482000.00
RXST cash_flow (quarterly, 2025-12-31) — Change In Inventory: -3225000.00
RXST cash_flow (annual, 2025-12-31) — Change In Payable: 627000.00
RXST cash_flow (quarterly, 2025-12-31) — Change In Payable: 2204000.00
RXST cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: -1248000.00
RXST cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: 3902000.00
RXST cash_flow (annual, 2025-12-31) — Change In Prepaid Assets: 1183000.00
RXST cash_flow (quarterly, 2025-12-31) — Change In Prepaid Assets: -881000.00
RXST cash_flow (annual, 2025-12-31) — Change In Receivables: 6655000.00
RXST cash_flow (quarterly, 2025-12-31) — Change In Receivables: 788000.00
RXST cash_flow (annual, 2025-12-31) — Change In Working Capital: -4892000.00
RXST cash_flow (quarterly, 2025-12-31) — Change In Working Capital: 584000.00
RXST cash_flow (annual, 2025-12-31) — Changes In Account Receivables: 6655000.00
RXST cash_flow (quarterly, 2025-12-31) — Changes In Account Receivables: 788000.00
RXST cash_flow (annual, 2025-12-31) — Changes In Cash: 3240000.00
RXST cash_flow (quarterly, 2025-12-31) — Changes In Cash: -9668000.00
RXST balance_sheet (annual, 2025-12-31) — Common Stock: 41000.00
RXST balance_sheet (quarterly, 2025-12-31) — Common Stock: 41000.00
RXST balance_sheet (annual, 2025-12-31) — Common Stock Equity: 275683000.00
RXST balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 275683000.00
RXST cash_flow (annual, 2025-12-31) — Common Stock Issuance: 3951000.00
RXST cash_flow (quarterly, 2025-12-31) — Common Stock Issuance: 1056000.00
RXST balance_sheet (annual, 2025-12-31) — Construction In Progress: 1720000.00
RXST balance_sheet (quarterly, 2025-12-31) — Construction In Progress: 1720000.00
RXST income_statement (annual, 2025-12-31) — Cost Of Revenue: 31470000.00
RXST income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 7345000.00
RXST balance_sheet (annual, 2025-12-31) — Current Assets: 287459000.00
RXST balance_sheet (quarterly, 2025-12-31) — Current Assets: 287459000.00
RXST balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 1162000.00
RXST balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 1162000.00
RXST balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 1162000.00
RXST balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 1162000.00
RXST balance_sheet (annual, 2025-12-31) — Current Deferred Liabilities: 3600000.00
RXST balance_sheet (quarterly, 2025-12-31) — Current Deferred Liabilities: 3600000.00
RXST balance_sheet (annual, 2025-12-31) — Current Deferred Revenue: 3600000.00
RXST balance_sheet (quarterly, 2025-12-31) — Current Deferred Revenue: 3600000.00
RXST balance_sheet (annual, 2025-12-31) — Current Liabilities: 26253000.00
RXST balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 26253000.00
RXST cash_flow (annual, 2025-12-31) — Depreciation: 3266000.00
RXST cash_flow (quarterly, 2025-12-31) — Depreciation: 851000.00
RXST cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 3266000.00
RXST cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 851000.00
RXST cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 3266000.00
RXST cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 851000.00
RXST income_statement (annual, 2025-12-31) — Diluted Average Shares: 40850739.00
RXST income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 41175725.00
RXST income_statement (annual, 2025-12-31) — Diluted EPS: -0.95
RXST income_statement (quarterly, 2025-12-31) — Diluted EPS: -0.22
RXST income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: -38944000.00
RXST income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: -9152000.00
RXST income_statement (annual, 2025-12-31) — EBIT: -38859000.00
RXST income_statement (quarterly, 2025-12-31) — EBIT: -9142000.00
RXST income_statement (annual, 2025-12-31) — EBITDA: -35593000.00
RXST income_statement (quarterly, 2025-12-31) — EBITDA: -8291000.00
RXST cash_flow (annual, 2025-12-31) — Effect Of Exchange Rate Changes: 3000.00
RXST cash_flow (quarterly, 2025-12-31) — Effect Of Exchange Rate Changes: -15000.00
RXST cash_flow (annual, 2025-12-31) — End Cash Position: 20699000.00
RXST cash_flow (quarterly, 2025-12-31) — End Cash Position: 20699000.00
RXST cash_flow (annual, 2025-12-31) — Financing Cash Flow: 1863000.00
RXST cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: 1063000.00
RXST balance_sheet (annual, 2025-12-31) — Finished Goods: 21635000.00
RXST balance_sheet (quarterly, 2025-12-31) — Finished Goods: 21635000.00
RXST cash_flow (annual, 2025-12-31) — Free Cash Flow: -19341000.00
RXST cash_flow (quarterly, 2025-12-31) — Free Cash Flow: -2253000.00
RXST balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 53000.00
RXST balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 53000.00
RXST balance_sheet (annual, 2025-12-31) — Gross PPE: 49583000.00
RXST balance_sheet (quarterly, 2025-12-31) — Gross PPE: 49583000.00
RXST income_statement (annual, 2025-12-31) — Gross Profit: 103009000.00
RXST income_statement (quarterly, 2025-12-31) — Gross Profit: 25263000.00
RXST cash_flow (annual, 2025-12-31) — Income Tax Paid Supplemental Data: 58000.00
RXST cash_flow (quarterly, 2025-12-31) — Income Tax Paid Supplemental Data: -12000.00
RXST income_statement (annual, 2025-12-31) — Interest Expense: 19000.00
RXST income_statement (quarterly, 2025-12-31) — Interest Expense: 5000.00
RXST income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 19000.00
RXST income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 5000.00
RXST income_statement (annual, 2025-12-31) — Interest Income: 9332000.00
RXST income_statement (quarterly, 2025-12-31) — Interest Income: 2195000.00
RXST income_statement (annual, 2025-12-31) — Interest Income Non Operating: 9332000.00
RXST income_statement (quarterly, 2025-12-31) — Interest Income Non Operating: 2195000.00
RXST cash_flow (annual, 2025-12-31) — Interest Paid Supplemental Data: 0.00
RXST balance_sheet (annual, 2025-12-31) — Inventories Adjustments Allowances: -1972000.00
RXST balance_sheet (quarterly, 2025-12-31) — Inventories Adjustments Allowances: -1972000.00
RXST balance_sheet (annual, 2025-12-31) — Inventory: 31559000.00
RXST balance_sheet (quarterly, 2025-12-31) — Inventory: 31559000.00
RXST balance_sheet (annual, 2025-12-31) — Invested Capital: 275683000.00
RXST balance_sheet (quarterly, 2025-12-31) — Invested Capital: 275683000.00
RXST cash_flow (annual, 2025-12-31) — Investing Cash Flow: 16889000.00
RXST cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -9614000.00
RXST cash_flow (annual, 2025-12-31) — Issuance Of Capital Stock: 3951000.00
RXST cash_flow (quarterly, 2025-12-31) — Issuance Of Capital Stock: 1056000.00
RXST cash_flow (annual, 2025-12-31) — Issuance Of Debt: 0.00
RXST balance_sheet (annual, 2025-12-31) — Leases: 15166000.00
RXST balance_sheet (quarterly, 2025-12-31) — Leases: 15166000.00
RXST balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 9878000.00
RXST balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 9878000.00
RXST balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 9878000.00
RXST balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 9878000.00
RXST cash_flow (annual, 2025-12-31) — Long Term Debt Issuance: 0.00
RXST cash_flow (annual, 2025-12-31) — Long Term Debt Payments: -26000.00
RXST cash_flow (quarterly, 2025-12-31) — Long Term Debt Payments: 9000.00
RXST balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 20992000.00
RXST balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 20992000.00
RXST cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: 3951000.00
RXST cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: 1056000.00
RXST income_statement (annual, 2025-12-31) — Net Income: -38944000.00
RXST income_statement (quarterly, 2025-12-31) — Net Income: -9152000.00
RXST income_statement (annual, 2025-12-31) — Net Income Common Stockholders: -38944000.00
RXST income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: -9152000.00
RXST income_statement (annual, 2025-12-31) — Net Income Continuous Operations: -38944000.00
RXST income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: -9152000.00
RXST income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -38944000.00
RXST income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -9152000.00
RXST income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -38944000.00
RXST income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -9152000.00
RXST cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: -38944000.00
RXST cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: -9152000.00
RXST income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: -38944000.00
RXST income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: -9152000.00
RXST income_statement (annual, 2025-12-31) — Net Interest Income: 9313000.00
RXST income_statement (quarterly, 2025-12-31) — Net Interest Income: 2190000.00
RXST cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: 20719000.00
RXST cash_flow (quarterly, 2025-12-31) — Net Investment Purchase And Sale: -8477000.00
RXST cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: -26000.00
RXST cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: 9000.00
RXST cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: -26000.00
RXST cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: 9000.00
RXST income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: 9313000.00
RXST income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: 2190000.00
RXST cash_flow (annual, 2025-12-31) — Net Other Financing Charges: -2062000.00
RXST cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: -2000.00
RXST balance_sheet (annual, 2025-12-31) — Net PPE: 23015000.00
RXST balance_sheet (quarterly, 2025-12-31) — Net PPE: 23015000.00
RXST cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -3830000.00
RXST cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: -1137000.00
RXST balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 275683000.00
RXST balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 275683000.00
RXST income_statement (annual, 2025-12-31) — Normalized EBITDA: -35593000.00
RXST income_statement (quarterly, 2025-12-31) — Normalized EBITDA: -8291000.00
RXST income_statement (annual, 2025-12-31) — Normalized Income: -38944000.00
RXST income_statement (quarterly, 2025-12-31) — Normalized Income: -9152000.00
RXST cash_flow (annual, 2025-12-31) — Operating Cash Flow: -15511000.00
RXST cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: -1116000.00
RXST income_statement (annual, 2025-12-31) — Operating Income: -48191000.00
RXST income_statement (quarterly, 2025-12-31) — Operating Income: -11337000.00
RXST income_statement (annual, 2025-12-31) — Operating Revenue: 134479000.00
RXST income_statement (quarterly, 2025-12-31) — Operating Revenue: 32608000.00
RXST balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 41242005.00
RXST balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 41242005.00
RXST balance_sheet (annual, 2025-12-31) — Other Current Assets: 4389000.00
RXST balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 4389000.00
RXST balance_sheet (annual, 2025-12-31) — Other Current Liabilities: 5705000.00
RXST balance_sheet (quarterly, 2025-12-31) — Other Current Liabilities: 5705000.00
RXST balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: 53000.00
RXST balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: 53000.00
RXST balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 1340000.00
RXST balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 1340000.00
RXST balance_sheet (annual, 2025-12-31) — Other Properties: 11705000.00
RXST balance_sheet (quarterly, 2025-12-31) — Other Properties: 11705000.00
RXST balance_sheet (annual, 2025-12-31) — Other Short Term Investments: 208179000.00
RXST balance_sheet (quarterly, 2025-12-31) — Other Short Term Investments: 208179000.00
RXST balance_sheet (annual, 2025-12-31) — Payables: 5296000.00
RXST balance_sheet (quarterly, 2025-12-31) — Payables: 5296000.00
RXST balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 5296000.00
RXST balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 5296000.00
RXST balance_sheet (annual, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 10490000.00
RXST balance_sheet (quarterly, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 10490000.00
RXST balance_sheet (annual, 2025-12-31) — Preferred Stock: 0.00
RXST balance_sheet (quarterly, 2025-12-31) — Preferred Stock: 0.00
RXST income_statement (annual, 2025-12-31) — Pretax Income: -38878000.00
RXST income_statement (quarterly, 2025-12-31) — Pretax Income: -9147000.00
RXST balance_sheet (annual, 2025-12-31) — Properties: 0.00
RXST balance_sheet (quarterly, 2025-12-31) — Properties: 0.00
RXST cash_flow (annual, 2025-12-31) — Provisionand Write Offof Assets: 1964000.00
RXST cash_flow (quarterly, 2025-12-31) — Provisionand Write Offof Assets: 616000.00
RXST cash_flow (annual, 2025-12-31) — Purchase Of Investment: -239281000.00
RXST cash_flow (quarterly, 2025-12-31) — Purchase Of Investment: -98477000.00
RXST cash_flow (annual, 2025-12-31) — Purchase Of PPE: -3830000.00
RXST cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: -1137000.00
RXST balance_sheet (annual, 2025-12-31) — Raw Materials: 8341000.00
RXST balance_sheet (quarterly, 2025-12-31) — Raw Materials: 8341000.00
RXST balance_sheet (annual, 2025-12-31) — Receivables: 23383000.00
RXST balance_sheet (quarterly, 2025-12-31) — Receivables: 23383000.00
RXST income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 31470000.00
RXST income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 7345000.00
RXST income_statement (annual, 2025-12-31) — Reconciled Depreciation: 3266000.00
RXST income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 851000.00
RXST cash_flow (annual, 2025-12-31) — Repayment Of Debt: -26000.00
RXST cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: 9000.00
RXST income_statement (annual, 2025-12-31) — Research And Development: 38549000.00
RXST income_statement (quarterly, 2025-12-31) — Research And Development: 8905000.00
RXST balance_sheet (annual, 2025-12-31) — Retained Earnings: -661039000.00
RXST balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -661039000.00
RXST cash_flow (annual, 2025-12-31) — Sale Of Investment: 260000000.00
RXST cash_flow (quarterly, 2025-12-31) — Sale Of Investment: 90000000.00
RXST income_statement (annual, 2025-12-31) — Selling General And Administration: 112651000.00
RXST income_statement (quarterly, 2025-12-31) — Selling General And Administration: 27695000.00
RXST balance_sheet (annual, 2025-12-31) — Share Issued: 41242005.00
RXST balance_sheet (quarterly, 2025-12-31) — Share Issued: 41242005.00
RXST income_statement (annual, 2025-12-31) — Special Income Charges: 0.00
RXST cash_flow (annual, 2025-12-31) — Stock Based Compensation: 31612000.00
RXST cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 7817000.00
RXST balance_sheet (annual, 2025-12-31) — Stockholders Equity: 275683000.00
RXST balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 275683000.00
RXST balance_sheet (annual, 2025-12-31) — Tangible Book Value: 275683000.00
RXST balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 275683000.00
RXST income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
RXST income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
RXST income_statement (annual, 2025-12-31) — Tax Provision: 66000.00
RXST income_statement (quarterly, 2025-12-31) — Tax Provision: 5000.00
RXST income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.21
RXST income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.21
RXST balance_sheet (annual, 2025-12-31) — Total Assets: 311814000.00
RXST balance_sheet (quarterly, 2025-12-31) — Total Assets: 311814000.00
RXST balance_sheet (annual, 2025-12-31) — Total Capitalization: 275683000.00
RXST balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 275683000.00
RXST balance_sheet (annual, 2025-12-31) — Total Debt: 11040000.00
RXST balance_sheet (quarterly, 2025-12-31) — Total Debt: 11040000.00
RXST balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 275683000.00
RXST balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 275683000.00
RXST income_statement (annual, 2025-12-31) — Total Expenses: 182670000.00
RXST income_statement (quarterly, 2025-12-31) — Total Expenses: 43945000.00
RXST balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 36131000.00
RXST balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 36131000.00
RXST balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 24355000.00
RXST balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 24355000.00
RXST balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 9878000.00
RXST balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 9878000.00
RXST income_statement (annual, 2025-12-31) — Total Operating Income As Reported: -48191000.00
RXST income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: -11337000.00
RXST income_statement (annual, 2025-12-31) — Total Unusual Items: 0.00
RXST income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: 0.00
RXST balance_sheet (annual, 2025-12-31) — Work In Process: 3555000.00
RXST balance_sheet (quarterly, 2025-12-31) — Work In Process: 3555000.00
RXST balance_sheet (annual, 2025-12-31) — Working Capital: 261206000.00
RXST balance_sheet (quarterly, 2025-12-31) — Working Capital: 261206000.00
RXST income_statement (quarterly, 2026-03-31) — +Operating Expense: 41327000.00
RXST income_statement (quarterly, 2026-03-31) — +Total Revenue: 30893000.00
RXST balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 7124000.00
RXST balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 22443000.00
RXST balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 944244000.00
RXST cash_flow (quarterly, 2026-03-31) — Amortization Of Securities: -1854000.00
RXST income_statement (quarterly, 2026-03-31) — Basic Average Shares: 41306110.00
RXST income_statement (quarterly, 2026-03-31) — Basic EPS: -0.38
RXST cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 20699000.00
RXST cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -759000.00
RXST balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 10826000.00
RXST balance_sheet (quarterly, 2026-03-31) — Capital Stock: 41000.00
RXST balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 17573000.00
RXST balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 217880000.00
RXST cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: -336000.00
RXST cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: 8848000.00
RXST cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: -10891000.00
RXST cash_flow (quarterly, 2026-03-31) — Change In Account Payable: 1577000.00
RXST cash_flow (quarterly, 2026-03-31) — Change In Accrued Expense: -1255000.00
RXST cash_flow (quarterly, 2026-03-31) — Change In Inventory: -3370000.00
RXST cash_flow (quarterly, 2026-03-31) — Change In Payable: 1577000.00
RXST cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: 322000.00
RXST cash_flow (quarterly, 2026-03-31) — Change In Prepaid Assets: 120000.00
RXST cash_flow (quarterly, 2026-03-31) — Change In Receivables: 936000.00
RXST cash_flow (quarterly, 2026-03-31) — Change In Working Capital: -1992000.00
RXST cash_flow (quarterly, 2026-03-31) — Changes In Account Receivables: 936000.00
RXST cash_flow (quarterly, 2026-03-31) — Changes In Cash: -2379000.00
RXST balance_sheet (quarterly, 2026-03-31) — Common Stock: 41000.00
RXST balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 267295000.00
RXST cash_flow (quarterly, 2026-03-31) — Common Stock Issuance: 144000.00
RXST income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 7395000.00
RXST balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 18748000.00
RXST balance_sheet (quarterly, 2026-03-31) — Current Assets: 279225000.00
RXST balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 1504000.00
RXST balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 1504000.00
RXST balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 27376000.00
RXST cash_flow (quarterly, 2026-03-31) — Depreciation: 834000.00
RXST cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 834000.00
RXST cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 834000.00
RXST income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 41306110.00
RXST income_statement (quarterly, 2026-03-31) — Diluted EPS: -0.38
RXST income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: -15884000.00
RXST income_statement (quarterly, 2026-03-31) — EBIT: -15875000.00
RXST income_statement (quarterly, 2026-03-31) — EBITDA: -15041000.00
RXST cash_flow (quarterly, 2026-03-31) — Effect Of Exchange Rate Changes: 3000.00
RXST cash_flow (quarterly, 2026-03-31) — End Cash Position: 18323000.00
RXST cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: -336000.00
RXST balance_sheet (quarterly, 2026-03-31) — Finished Goods: 23173000.00
RXST cash_flow (quarterly, 2026-03-31) — Free Cash Flow: -11650000.00
RXST balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: -67000.00
RXST balance_sheet (quarterly, 2026-03-31) — Gross PPE: 22992000.00
RXST income_statement (quarterly, 2026-03-31) — Gross Profit: 23498000.00
RXST cash_flow (quarterly, 2026-03-31) — Income Tax Paid Supplemental Data: 0.00
RXST income_statement (quarterly, 2026-03-31) — Interest Expense: 3000.00
RXST income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 3000.00
RXST income_statement (quarterly, 2026-03-31) — Interest Income: 1954000.00
RXST income_statement (quarterly, 2026-03-31) — Interest Income Non Operating: 1954000.00
RXST balance_sheet (quarterly, 2026-03-31) — Inventories Adjustments Allowances: -1793000.00
RXST balance_sheet (quarterly, 2026-03-31) — Inventory: 34869000.00
RXST balance_sheet (quarterly, 2026-03-31) — Invested Capital: 267295000.00
RXST cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: 8848000.00
RXST cash_flow (quarterly, 2026-03-31) — Issuance Of Capital Stock: 144000.00
RXST balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 9322000.00
RXST balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 9322000.00
RXST cash_flow (quarterly, 2026-03-31) — Long Term Debt Payments: -7000.00
RXST cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: 144000.00
RXST income_statement (quarterly, 2026-03-31) — Net Income: -15884000.00
RXST income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: -15884000.00
RXST income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: -15884000.00
RXST income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: -15884000.00
RXST income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: -15884000.00
RXST cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: -15884000.00
RXST income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: -15884000.00
RXST income_statement (quarterly, 2026-03-31) — Net Interest Income: 1951000.00
RXST cash_flow (quarterly, 2026-03-31) — Net Investment Purchase And Sale: 9607000.00
RXST cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: -7000.00
RXST cash_flow (quarterly, 2026-03-31) — Net Long Term Debt Issuance: -7000.00
RXST income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: 1951000.00
RXST cash_flow (quarterly, 2026-03-31) — Net Other Financing Charges: -473000.00
RXST balance_sheet (quarterly, 2026-03-31) — Net PPE: 22992000.00
RXST cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: -759000.00
RXST balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 267295000.00
RXST income_statement (quarterly, 2026-03-31) — Normalized EBITDA: -15041000.00
RXST income_statement (quarterly, 2026-03-31) — Normalized Income: -15884000.00
RXST cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: -10891000.00
RXST income_statement (quarterly, 2026-03-31) — Operating Income: -17829000.00
RXST income_statement (quarterly, 2026-03-31) — Operating Revenue: 30893000.00
RXST balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 41384120.00
RXST balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 4033000.00
RXST balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: -67000.00
RXST balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 1776000.00
RXST balance_sheet (quarterly, 2026-03-31) — Other Properties: 9760000.00
RXST balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 200307000.00
RXST balance_sheet (quarterly, 2026-03-31) — Payables: 7124000.00
RXST balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 25872000.00
RXST balance_sheet (quarterly, 2026-03-31) — Preferred Stock: 0.00
RXST income_statement (quarterly, 2026-03-31) — Pretax Income: -15878000.00
RXST balance_sheet (quarterly, 2026-03-31) — Properties: 13232000.00
RXST cash_flow (quarterly, 2026-03-31) — Provisionand Write Offof Assets: 60000.00
RXST cash_flow (quarterly, 2026-03-31) — Purchase Of Investment: -100393000.00
RXST cash_flow (quarterly, 2026-03-31) — Purchase Of PPE: -759000.00
RXST balance_sheet (quarterly, 2026-03-31) — Raw Materials: 7978000.00
RXST balance_sheet (quarterly, 2026-03-31) — Receivables: 22443000.00
RXST income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 7395000.00
RXST income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 834000.00
RXST cash_flow (quarterly, 2026-03-31) — Repayment Of Debt: -7000.00
RXST income_statement (quarterly, 2026-03-31) — Research And Development: 9472000.00
RXST balance_sheet (quarterly, 2026-03-31) — Retained Earnings: -676923000.00
RXST cash_flow (quarterly, 2026-03-31) — Sale Of Investment: 110000000.00
RXST income_statement (quarterly, 2026-03-31) — Selling General And Administration: 31855000.00
RXST balance_sheet (quarterly, 2026-03-31) — Share Issued: 41384120.00
RXST cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 7945000.00
RXST balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 267295000.00
RXST balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 267295000.00
RXST income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
RXST income_statement (quarterly, 2026-03-31) — Tax Provision: 6000.00
RXST income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.40
RXST balance_sheet (quarterly, 2026-03-31) — Total Assets: 303993000.00
RXST balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 267295000.00
RXST balance_sheet (quarterly, 2026-03-31) — Total Debt: 10826000.00
RXST balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 267295000.00
RXST income_statement (quarterly, 2026-03-31) — Total Expenses: 48722000.00
RXST balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 36698000.00
RXST balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 24768000.00
RXST balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 9322000.00
RXST income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: -17829000.00
RXST balance_sheet (quarterly, 2026-03-31) — Work In Process: 5511000.00
RXST balance_sheet (quarterly, 2026-03-31) — Working Capital: 251849000.00
RXT cash_flow (annual, 2021-12-31) — Common Stock Issuance: 0.00
RXT cash_flow (annual, 2021-12-31) — Gain Loss On Sale Of Business: 0.00
RXT cash_flow (annual, 2021-12-31) — Gain Loss On Sale Of PPE: -19900000.00
RXT income_statement (annual, 2021-12-31) — Gain On Sale Of Business: 0.00
RXT income_statement (annual, 2021-12-31) — Gain On Sale Of Ppe: 19900000.00
RXT cash_flow (annual, 2021-12-31) — Issuance Of Capital Stock: 0.00
RXT balance_sheet (annual, 2021-12-31) — Land And Improvements: 21200000.00
RXT cash_flow (annual, 2021-12-31) — Net Investment Purchase And Sale: 0.00
RXT income_statement (annual, 2021-12-31) — Other Special Charges: 37500000.00
RXT cash_flow (annual, 2021-12-31) — Purchase Of Business: 0.00
RXT cash_flow (annual, 2021-12-31) — Purchase Of Investment: 0.00
RXT cash_flow (annual, 2021-12-31) — Sale Of Investment: 0.00
RXT cash_flow (annual, 2021-12-31) — Sale Of PPE: 31300000.00
RXT income_statement (annual, 2021-12-31) — Write Off: 0.00
RXT income_statement (annual, 2022-12-31) — +Operating Expense: 855300000.00
RXT income_statement (annual, 2022-12-31) — +Total Revenue: 3122300000.00
RXT balance_sheet (annual, 2022-12-31) — Accounts Payable: 447300000.00
RXT balance_sheet (annual, 2022-12-31) — Accounts Receivable: 622200000.00
RXT balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -1400300000.00
RXT balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 2573300000.00
RXT balance_sheet (annual, 2022-12-31) — Allowance For Doubtful Accounts Receivable: -24600000.00
RXT cash_flow (annual, 2022-12-31) — Amortization Cash Flow: 166800000.00
RXT cash_flow (annual, 2022-12-31) — Amortization Of Intangibles: 166800000.00
RXT cash_flow (annual, 2022-12-31) — Asset Impairment Charge: 680600000.00
RXT income_statement (annual, 2022-12-31) — Basic Average Shares: 211200000.00
RXT income_statement (annual, 2022-12-31) — Basic EPS: -3.81
RXT cash_flow (annual, 2022-12-31) — Beginning Cash Position: 275400000.00
RXT balance_sheet (annual, 2022-12-31) — Buildings And Improvements: 402200000.00
RXT cash_flow (annual, 2022-12-31) — Capital Expenditure: -80400000.00
RXT balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 533700000.00
RXT balance_sheet (annual, 2022-12-31) — Capital Stock: 2200000.00
RXT balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 228400000.00
RXT balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 228400000.00
RXT cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: -187000000.00
RXT cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: -97900000.00
RXT cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: 246600000.00
RXT cash_flow (annual, 2022-12-31) — Change In Account Payable: 69800000.00
RXT cash_flow (annual, 2022-12-31) — Change In Other Current Liabilities: -65500000.00
RXT cash_flow (annual, 2022-12-31) — Change In Other Working Capital: 5700000.00
RXT cash_flow (annual, 2022-12-31) — Change In Payable: 69800000.00
RXT cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: 69800000.00
RXT cash_flow (annual, 2022-12-31) — Change In Prepaid Assets: -7100000.00
RXT cash_flow (annual, 2022-12-31) — Change In Receivables: -82400000.00
RXT cash_flow (annual, 2022-12-31) — Change In Working Capital: -79500000.00
RXT cash_flow (annual, 2022-12-31) — Changes In Account Receivables: -82400000.00
RXT cash_flow (annual, 2022-12-31) — Changes In Cash: -38200000.00
RXT balance_sheet (annual, 2022-12-31) — Common Stock: 2200000.00
RXT balance_sheet (annual, 2022-12-31) — Common Stock Equity: 629500000.00
RXT cash_flow (annual, 2022-12-31) — Common Stock Issuance: 0.00
RXT cash_flow (annual, 2022-12-31) — Common Stock Payments: -31000000.00
RXT balance_sheet (annual, 2022-12-31) — Construction In Progress: 15200000.00
RXT income_statement (annual, 2022-12-31) — Cost Of Revenue: 2265400000.00
RXT balance_sheet (annual, 2022-12-31) — Current Accrued Expenses: 36300000.00
RXT balance_sheet (annual, 2022-12-31) — Current Assets: 1073200000.00
RXT balance_sheet (annual, 2022-12-31) — Current Capital Lease Obligation: 138400000.00
RXT balance_sheet (annual, 2022-12-31) — Current Debt: 23000000.00
RXT balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 161400000.00
RXT balance_sheet (annual, 2022-12-31) — Current Deferred Liabilities: 80900000.00
RXT balance_sheet (annual, 2022-12-31) — Current Deferred Revenue: 80900000.00
RXT balance_sheet (annual, 2022-12-31) — Current Liabilities: 856500000.00
RXT cash_flow (annual, 2022-12-31) — Deferred Income Tax: -108800000.00
RXT cash_flow (annual, 2022-12-31) — Deferred Tax: -108800000.00
RXT cash_flow (annual, 2022-12-31) — Depreciation: 280700000.00
RXT cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 447500000.00
RXT cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 447500000.00
RXT income_statement (annual, 2022-12-31) — Diluted Average Shares: 211200000.00
RXT income_statement (annual, 2022-12-31) — Diluted EPS: -3.81
RXT income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: -804800000.00
RXT income_statement (annual, 2022-12-31) — EBIT: -689200000.00
RXT income_statement (annual, 2022-12-31) — EBITDA: -241700000.00
RXT cash_flow (annual, 2022-12-31) — Effect Of Exchange Rate Changes: -5800000.00
RXT cash_flow (annual, 2022-12-31) — End Cash Position: 231400000.00
RXT cash_flow (annual, 2022-12-31) — Financing Cash Flow: -187000000.00
RXT cash_flow (annual, 2022-12-31) — Free Cash Flow: 166300000.00
RXT cash_flow (annual, 2022-12-31) — Gain Loss On Investment Securities: 18700000.00
RXT cash_flow (annual, 2022-12-31) — Gain Loss On Sale Of PPE: 0.00
RXT income_statement (annual, 2022-12-31) — Gain On Sale Of Ppe: 0.00
RXT income_statement (annual, 2022-12-31) — Gain On Sale Of Security: -200000.00
RXT balance_sheet (annual, 2022-12-31) — Gains Losses Not Affecting Retained Earnings: 71400000.00
RXT balance_sheet (annual, 2022-12-31) — Goodwill: 2155100000.00
RXT balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 3391100000.00
RXT balance_sheet (annual, 2022-12-31) — Gross Accounts Receivable: 646800000.00
RXT balance_sheet (annual, 2022-12-31) — Gross PPE: 2166600000.00
RXT income_statement (annual, 2022-12-31) — Gross Profit: 856900000.00
RXT income_statement (annual, 2022-12-31) — Impairment Of Capital Assets: 680600000.00
RXT cash_flow (annual, 2022-12-31) — Income Tax Paid Supplemental Data: 10500000.00
RXT income_statement (annual, 2022-12-31) — Interest Expense: 208500000.00
RXT income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 208500000.00
RXT cash_flow (annual, 2022-12-31) — Interest Paid Supplemental Data: 177900000.00
RXT balance_sheet (annual, 2022-12-31) — Interest Payable: 36300000.00
RXT balance_sheet (annual, 2022-12-31) — Invested Capital: 3947900000.00
RXT cash_flow (annual, 2022-12-31) — Investing Cash Flow: -97900000.00
RXT cash_flow (annual, 2022-12-31) — Issuance Of Capital Stock: 0.00
RXT cash_flow (annual, 2022-12-31) — Issuance Of Debt: 0.00
RXT balance_sheet (annual, 2022-12-31) — Land And Improvements: 0.00
RXT balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 395300000.00
RXT balance_sheet (annual, 2022-12-31) — Long Term Debt: 3295400000.00
RXT balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 3690700000.00
RXT cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 0.00
RXT cash_flow (annual, 2022-12-31) — Long Term Debt Payments: -90200000.00
RXT balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 1611200000.00
RXT cash_flow (annual, 2022-12-31) — Net Business Purchase And Sale: -7700000.00
RXT cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: -31000000.00
RXT balance_sheet (annual, 2022-12-31) — Net Debt: 3090000000.00
RXT income_statement (annual, 2022-12-31) — Net Income: -804800000.00
RXT income_statement (annual, 2022-12-31) — Net Income Common Stockholders: -804800000.00
RXT income_statement (annual, 2022-12-31) — Net Income Continuous Operations: -804800000.00
RXT income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: -804800000.00
RXT income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: -804800000.00
RXT cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: -804800000.00
RXT income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: -804800000.00
RXT income_statement (annual, 2022-12-31) — Net Interest Income: -208500000.00
RXT cash_flow (annual, 2022-12-31) — Net Investment Purchase And Sale: -15000000.00
RXT cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: -90200000.00
RXT cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: -90200000.00
RXT income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: -208500000.00
RXT cash_flow (annual, 2022-12-31) — Net Other Financing Charges: -69500000.00
RXT cash_flow (annual, 2022-12-31) — Net Other Investing Changes: 5200000.00
RXT balance_sheet (annual, 2022-12-31) — Net PPE: 766300000.00
RXT cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -80400000.00
RXT balance_sheet (annual, 2022-12-31) — Net Tangible Assets: -2761600000.00
RXT balance_sheet (annual, 2022-12-31) — Non Current Deferred Liabilities: 126700000.00
RXT balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Liabilities: 126700000.00
RXT income_statement (annual, 2022-12-31) — Normalized EBITDA: 439100000.00
RXT income_statement (annual, 2022-12-31) — Normalized Income: -194122400.00
RXT cash_flow (annual, 2022-12-31) — Operating Cash Flow: 246700000.00
RXT cash_flow (annual, 2022-12-31) — Operating Gains Losses: 18700000.00
RXT income_statement (annual, 2022-12-31) — Operating Income: 1600000.00
RXT income_statement (annual, 2022-12-31) — Operating Revenue: 3122300000.00
RXT balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 211200000.00
RXT balance_sheet (annual, 2022-12-31) — Other Current Assets: 125300000.00
RXT balance_sheet (annual, 2022-12-31) — Other Current Borrowings: 23000000.00
RXT balance_sheet (annual, 2022-12-31) — Other Current Liabilities: 35300000.00
RXT balance_sheet (annual, 2022-12-31) — Other Equity Adjustments: 71400000.00
RXT income_statement (annual, 2022-12-31) — Other Income Expense: -690800000.00
RXT balance_sheet (annual, 2022-12-31) — Other Intangible Assets: 1236000000.00
RXT cash_flow (annual, 2022-12-31) — Other Non Cash Items: 11100000.00
RXT balance_sheet (annual, 2022-12-31) — Other Non Current Assets: 226100000.00
RXT balance_sheet (annual, 2022-12-31) — Other Non Current Liabilities: 153300000.00
RXT income_statement (annual, 2022-12-31) — Other Non Operating Income Expenses: -10000000.00
RXT balance_sheet (annual, 2022-12-31) — Other Properties: 138000000.00
RXT balance_sheet (annual, 2022-12-31) — Payables: 447300000.00
RXT balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 483600000.00
RXT balance_sheet (annual, 2022-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 95300000.00
RXT balance_sheet (annual, 2022-12-31) — Preferred Stock: 0.00
RXT balance_sheet (annual, 2022-12-31) — Prepaid Assets: 97300000.00
RXT income_statement (annual, 2022-12-31) — Pretax Income: -897700000.00
RXT cash_flow (annual, 2022-12-31) — Proceeds From Stock Option Exercised: 3700000.00
RXT balance_sheet (annual, 2022-12-31) — Properties: 0.00
RXT cash_flow (annual, 2022-12-31) — Provisionand Write Offof Assets: 12400000.00
RXT cash_flow (annual, 2022-12-31) — Purchase Of Business: -7700000.00
RXT cash_flow (annual, 2022-12-31) — Purchase Of Investment: -15000000.00
RXT cash_flow (annual, 2022-12-31) — Purchase Of PPE: -80400000.00
RXT balance_sheet (annual, 2022-12-31) — Receivables: 622200000.00
RXT income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 2265400000.00
RXT income_statement (annual, 2022-12-31) — Reconciled Depreciation: 447500000.00
RXT cash_flow (annual, 2022-12-31) — Repayment Of Debt: -90200000.00
RXT cash_flow (annual, 2022-12-31) — Repurchase Of Capital Stock: -31000000.00
RXT balance_sheet (annual, 2022-12-31) — Retained Earnings: -1986400000.00
RXT cash_flow (annual, 2022-12-31) — Sale Of Business: 0.00
RXT cash_flow (annual, 2022-12-31) — Sale Of Investment: 0.00
RXT cash_flow (annual, 2022-12-31) — Sale Of PPE: 0.00
RXT income_statement (annual, 2022-12-31) — Selling General And Administration: 855300000.00
RXT balance_sheet (annual, 2022-12-31) — Share Issued: 211200000.00
RXT income_statement (annual, 2022-12-31) — Special Income Charges: -680600000.00
RXT cash_flow (annual, 2022-12-31) — Stock Based Compensation: 69500000.00